• Everyday Alpha
  • Posts
  • Everyday Value Meets Holiday Muscle With This Giant

Everyday Value Meets Holiday Muscle With This Giant

In partnership with

This company’s quarter was all about momentum you can actually see.

E-commerce kept sprinting, higher-income households kept crossing the aisle for value, and management nudged the full-year outlook higher again.

Delivery is faster, baskets are bigger, and advertising is turning digital traffic into real margin.

Rosé Can Have More Sugar Than Donuts?

No wonder 38% of adults prefer health-conscious beverages.

Meanwhile, companies like AMASS Brands are raking in sales by tapping into this trend, creating a huge opportunity for investors.

AMASS has made over $80M to date, including $33M in 2023 alone, thanks to products like their top-selling zero-sugar Summer Water rosé (it’s tariff-free, too). That’s just one of their portfolio’s 15+ diverse brands, already distributed across 40,000+ retail locations, including Whole Foods, Erewhon, and more.

It’s only the beginning. That’s why they just reserved the Nasdaq ticker $AMSS. Celebs like Adam Levine and Derek Jeter have already invested. And you now have the chance to join them before AMASS grows their retail footprint 3X by 2028.

But the window to secure up to 23% bonus stock ends soon. Maximize your stake as an early-stage AMASS Brands shareholder while you can.

This is a paid advertisement for AMASS’s Regulation CF offering. Please read the offering circular at https://invest.amassbrands.com

Never Miss a Stock Alert Again!

We now send our daily picks via SMS too — so you’ll get the same high-conviction ideas, even if you miss the email.

Walmart | WMT

Price: $105.32

The world’s busiest cart keeps rolling. Comp growth was solid, online sales jumped, and management lifted both sales and EPS guidance.

The mix is getting friendlier with more non-food, delivery speed is a real moat, and advertising continues to scale as marketplace SKUs expand. 

SNAP pauses during the shutdown pinched some weeks but the rebound is already visible.

Leadership change is in motion at the top, yet the operating cadence looks the same where it counts.

Why this matters for you: If you want steady exposure to the U.S. consumer, WMT gives you traffic, pricing power, and a growing ad flywheel.

Watch U.S. e-commerce growth, marketplace take rate, and gross margin mix through holiday. If those hold up, pullbacks can be adds.

Bath & Body Works | BBWI

Price: $14.85

Rough day at the candle bar. EPS and revenue missed, gross margin took a step back, and shares sank hard. 

Management is trimming adjacencies, leaning back into core fragrance and body care, and planning an Amazon launch in 2026 with a sizable cost-save program.

International is a bright spot, digital needs sharpening, and near-term growth looks muted while the reset runs its course.

Why this matters for you: Turnarounds take quarters, not weeks. If you are fishing here, size small and require proof.

Look for loyalty engagement to improve, direct channel declines to stabilize, and margin to recover as mix simplifies. No need to be early.

Market Movers (Sponsored)

A powerful shift in America’s AI landscape is underway, and a new group of companies is positioned to benefit.

A free report reveals 9 AI-driven operations showing strong revenue trends and real domestic expansion.

These picks come from sectors seeing faster adoption, lighter regulatory pressure and growing infrastructure demand.

Investors watching early indicators may find the timing advantageous.

Regeneron | REGN

Price: $755.90

Good news stacked up. Eylea HD won label wins that should ease injection burden and help retention, analysts nudged targets higher, and shares responded. 

The broader story remains durable with a clean balance sheet and multiple shots on goal across ophthalmology and oncology.

Execution on prefilled syringe and patient access funding can widen the runway in 2026.

Why this matters for you: If you like cash-rich innovators with real products, REGN fits. Track Eylea HD uptake with the new dosing flexibility, U.S. revenue cadence into 2026, and the regulatory drumbeat on upcoming add-ons.

Weak biotech tapes often give you chances to accumulate quality.

Clorox | CLX

Price: $103.92

Staples have been anything but boring this year. The stock sits near cycle lows after a long slide, and the latest update was governance housekeeping from the shareholder meeting. 

Under the hood, CLX still owns strong household brands, but the market wants cleaner execution, better price-pack architecture, and a steadier margin profile after prior disruptions.

Why this matters for you: Income investors may eye the yield, but you should demand improvement in gross margin and elasticities through holiday promos.

If private label pressure eases and service levels stay high, CLX can grind back. Until then, treat it as a show-me story.

Robinhood | HOOD

Price: $107.30

When markets wobble, trading apps feel it.

A stronger than expected jobs report tugged rate-cut odds lower, equities reversed, and the stock sold off as investors modeled softer activity. 

The franchise is bigger and cleaner than during the last crypto winter, but sentiment still sets the daily tape.

Valuation is rich for the growth rate, so the company needs consistent throughput and monetization to bridge the gap.

Why this matters for you: If you use HOOD as a levered read on retail participation, size like a cyclical. Watch net deposits, active traders, and net take rate.

Volatility spikes can be your friend, but you want proof that engagement holds when the market goes from party to porridge.

Poll: What’s the biggest emotional driver of money decisions today?

Login or Subscribe to participate in polls.

Stat of the Day: 119,000 jobs

The delayed September report showed the strongest payroll gain since April, while unemployment ticked up to 4.4%.

The data muddies the December rate call because it signals resilience with a softer undercurrent.

So keep an eye on rate-sensitive names and look for firms with price and cost control. Strength can live next to caution for a while.

Final Take

Two themes cut through the noise. Value and convenience pull shoppers into the same basket, and execution beats vibe. Walmart is a clean read on both.

Elsewhere, you want evidence. BBWI needs a reset to work, REGN has catalysts that can compound, CLX must rebuild trust on margin, and HOOD trades with the market’s mood.

Use red days to upgrade your average quality, and keep your watchlist tied to metrics you can actually track.

Best Regards,
—Noah Zelvis
Everyday Alpha